Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Debt / NOTE 3.000% 6/0
-
Market price (% of par)
-
80.11%
-
Total 13F principal
-
$130,554,870
-
Principal change
-
+$25,616,466
-
Total reported market value
-
$106,126,000
-
Number of holders
-
19
-
Value change
-
+$20,548,429
-
Number of buys
-
5
-
Number of sells
-
4
Institutional Holders of ARRAY BIOPHARMA INC - NOTE 3.000% 6/0 as of Q1 2016
As of 31 Mar 2016,
ARRAY BIOPHARMA INC - NOTE 3.000% 6/0 was held by
19 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$130,554,870
in principal (par value) of the bond.
The largest 10 bondholders included
DEERFIELD MANAGEMENT CO, EcoR1 Capital, LLC, WOLVERINE ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, ADVENT CAPITAL MANAGEMENT /DE/, BARCLAYS PLC, MACKAY SHIELDS LLC, QVT Financial LP, Redmile Group, LLC, and BAKER BROS. ADVISORS LP.
This page lists
19
institutional bondholders reporting positions
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.